ALBO-OLD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Albireo Pharma Inc. (ALBO-OLD).
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
N/A
ROIC, N/A FCF margin
Growth
N/A
5Y sales (revenue) CAGR
Balance sheet
N/A
Debt/equity, N/A current ratio
Superinvestors
1
Top: Meridian Contrarian Fund (0.1%)
Strengths to research
No strong positive screening signals were detected from the checked-in dataset.
Watchouts
- Full metrics are not available yet for this ticker.
Annual data: 0 periods
Quarterly data: 0 periods
Stock snapshot: N/A
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for ALBO-OLD.
Grade F
0
/ 100
Financial Charts
No financial data available for ALBO-OLD (annual).
1 superinvestors own ALBO-OLD
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Meridian Contrarian Fund Meridian Contrarian Fund | 150,750 | $350,000 | 0.07% | 0.0% |